My Short Biography:
Dr. Wang is the Director of the Stanford Cardiac Arrhythmia Service and Professor of Medicine and of Bioengineering (by courtesy). He has co-authored textbooks on implantable defibrillators, sudden cardiac death, cardiac resynchronization/ biventricular pacing therapy, and innovations in arrhythmia therapy. Dr. Wang participates on numerous national boards and panels in cardiac electrophysiology. Dr. Wang has been selected as the Editor-in-Chief of one of the field’s most pre-eminent journals, Circulation: Arrhythmia and Electrophysiology. He is a member of the American Heart Association Council on Clinical Cardiology, a member of the American Heart Association Science and Clinical Education Lifelong Learning (SCILL) Committee, and past Chair of the American Heart Association Council on Clinical Cardiology ECG and Arrhythmias Committee and the past member of the American College of Cardiology Electrophysiology Committee. He helped found the American Heart Association Arrhythmia Research Summit at the AHA Annual Scientific Sessions. He was previously a member of the Cardiac Electrophysiology Board Certification Exam Writing Committee of the American Board of Internal Medicine. He was past Chair of the CME Compliance Subcommittee and Vice-Chair of the Education Committee of the Heart Rhythm Society. He was an Associate Editor of the Heart Rhythm Journal. He is a former member of the Board of Trustees of the Heart Rhythm Society. Dr. Wang is Co-Director of the Bioengineering Scholarly Concentration of the Stanford School of Medicine. Dr. Wang directs the course Bioengineering 390, Introduction to Bioengineering Research. Dr. Wang with Dr. Paul Yock organizes an annual meeting, “Stanford Biodesign New Arrhythmia Technologies Retreat”, focusing on new technological advances in arrhythmia management and diagnosis. Dr. Wang is a member of the Stanford Biodesign Center program committee and the Center’s Faculty Liaison. Dr. Wang's research studies centers on the development of innovative approaches to the treatment of arrhythmias, including catheter ablation, implantable devices, and diagnostic techniques. Dr. Wang has invented a number of new arrhythmia technologies and has 17 issued patents. Dr. Wang is co-inventor of a cryoablation method and device that has been the basis of a cryoablation catheter which has been FDA approved (Cryocath, Inc. acquired by Medtronic, Inc.). Catheter cryoablation has been used in over 250,000 patients with atrial fibrillation and supraventricular tachycardias. Dr. Wang published the first report of balloon cryoablation in 2006. More recently, Dr. Wang has invented and patented a catheter device that is designed to walk on the inner surface of the heart. Dr. Wang has developed algorithms to improve rhythm detection including a technique for T wave subtraction to identify the P wave morphology of atrial arrhythmias. Recently Dr. Wang coauthored a best practices guide for cryoablation of atrial fibrillation based on 3000 procedures. Dr. Wang actively participates in FIRM related research and uses FIRM mapping regularly.
Clinical Electrophysiology and Catheter Ablation
This website is optimized for Chrome and Internet Explorer 11.